Gelenterum 250 mg
Ref 1308490Model Tasectan sachets
Active
CE MDR
Valid until
21 Dec 2028
FDA recalls
Not applicable
Documents
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR | NumberCSQ0016230226 | Date26 Feb 2026 | StatusActive |
Certificates
- CSQ0016230226 Active
Quality management system EU MDR
- Certifier
- ISTITUTO SUPERIORE DI SANITA' 0373
- Issued
- 26 Feb 2026
- Expires
- 21 Dec 2028
- Reason
- Mnf data change
- CVD0023230226 Active
Technical documentation EU MDR
- Certifier
- ISTITUTO SUPERIORE DI SANITA' 0373
- Issued
- 26 Feb 2026
- Expires
- 21 Dec 2028
- Reason
- Mnf data change
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/MDR Active
Specification
- Device Name
- Tasectan sachets
- Model / Reference
- Tasectan sachets, 1308490
- Primary DI / UDI-DI
- 08436593830090
- Basic UDI-DI
- 843659383TAS133M2
- Direct Marketing DI
- 08436593830090
- EMDN Code
- G99 Gastrointestinal devices - other
- Device Class
- Class III
- EU market of registration
- Italy
Manufacturer details
- EUDAMED SRN
- ES-MF-000000797
Other devices from Noventure S.L.U.
Properties
Other properties (12)
- Sterile: No
- Implantable: No
- Reusable: No
- Contains Latex: No
- Reprocessed: No
- CMR Substance: No
- Human-derived: No
- Human Tissues: No
- Endocrine Disruptor: No
- Administering Medicine: No
- Measuring Function: No
- Incorporates Medicinal Product: No